Status:

RECRUITING

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

NAFLD - Nonalcoholic Fatty Liver Disease

Diabetes

Eligibility:

All Genders

18+ years

Brief Summary

The main aim of the study is to set up an observational cohort with NAFLD (Non-alcoholic fatty liver disease) at different stage of disease (from simple steatosis to cirrhosis and/or HCC-Hepatocellula...

Detailed Description

Non-alcoholic fatty liver disease (NAFLD) is characterized by the excessive accumulation of triglycerides in the liver and is often associated, in the absence of significant alcohol consumption, to in...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Clinical phenotype of NAFLD (simple steatosis, NASH, metabolic cirrhosis, NAFLD-HCC) based on any of:
  • Liver biopsy providing histological evidence of NAFLD or,
  • Biochemical and/or radiological findings consistent with NAFLD
  • Average alcohol consumption ≤21/14 units/week (males/females) in preceding 6 months and no history of sustained excessive consumption of alcohol in past 5 years.
  • Clearance of HCV infection with new DAAs drugs with a SVR (sustained virological response) period \> 6 months
  • Presence of risk factors for NAFLD (i.e. diabetes, metabolic syndrome, obesity, psoriasis) and absence of fatty liver at US

Exclusion

  • Refusal or inability (lack of capacity) to give informed consent.
  • Average alcohol ingestion \>21/14 units/week (males/females) in preceding 6 months or history of sustained excessive consumption of alcohol in past 5 years.
  • History or presence of Type 1 diabetes mellitus.
  • Patients not meeting inclusion criteria or judged by the investigator to be unsuitable for inclusion in the study.

Key Trial Info

Start Date :

September 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2035

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT04371042

Start Date

September 1 2019

End Date

December 31 2035

Last Update

May 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Catholic University of Rome, Fondazione Policlinico Gemelli IRCCS

Roma, Rome/lazio/italy, Italy, 00168

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies | DecenTrialz